Case Report

A Case of Type 2 Diabetes Mellitus with Lung Cancer Suffered from Euglycemic Diabetic Ketosis Accompanied by Adrenal Insufficiency after Immune Checkpoint Inhibitors

Table 1

Patient laboratory data from the time of administration and the results of endocrine loading tests.

Complete blood countBiochemical blood test
WBC9640/μLAST26U/L
Neut64.2%ALT11U/L
Lymp18.6%LDH168U/L
Mono6.7%γ-GTP15U/L
Eos9.9%CPK464U/L
Baso0.6%TP6.0g/dL
RBC4.96 × 106/μLALB2.8g/dL
Hb14.3g/dLBUN26.3mg/dL
Ht44.2%Cr1.07mg/dL
PLT463 × 103/μLNa132mEq/L
Urinary testK5.1mEq/L
Specific gravity1.030Cl97mEq/L
pH6.0Modified Ca11.6mg/dL
Sugar(4+)P3.8mg/dL
Blood(−)CRP16.6mg/dL
Protein(−)NH321μg/dL
Ketone body(3+)T-Bil0.52mg/dL
WBC(−)AMY32U/L
Bacteria(−)Vit B1257.2ng/mL
Venous blood gasCortisol7.1μg/dL
pH7.40CYFRA3.0ng/mL
PCO228.7torreGFR53ml/min/L
PO277.0torrDiabetes/thyroid blood test
HCO317.4mmol/LGlucose121mg/dL
SBE−6.5mmol/LHbA1c9.3%
Lac7.0mg/dLC-peptide1.47ng/mL
Venous ketone bodyfreeT41.21ng/dL
Total ketone body7071μmol/LTSH2.850μIU/mL
Acetoacetic acid2076μmol/LGADA<5.0U/mL
3-hydroxybutyric acid4995μmol/LTg-Ab24.9U/mL
TPO-Ab3.0U/mL
Endocrine loading tests
Rapid-ACTH test
0 min30 min60 minUnit
ACTH<1.5pg/mL
Cortisol0.25.06.6μg/dL
CRH, TRH and GnRH loading tests
0 min30 min60 min90 minUnit
ATCH<1.54.72.0pg/mL
Cortisol0.51.20.9μg/dL
PRL33.393.186.7ng/mL
TSH2.349.549.01μIU/mL
LH6.633.038.0mIU/mL
FSH15.624.627.3mIU/mL
GHRP2 loading test
0 min15 min30 min45 min60 min
GH0.8882.696.478.743.9
IGF-1122(Units of GH, IGF-1; ng/mL)

CYFRA, cytokeratin 19 fragment; GADA, anti-glutamic acid decarboxylase antibody; Tg-Ab, anti-thyroglobulin antibody; TPO-Ab, anti-thyroid peroxidase antibody; ACTH, adrenocorticotropic hormone; PRL, prolactin; TSH, thyroid stimulating hormone; LH, luteinizing hormone; FSH, follicle stimulating hormone; GH, growth hormone; IGF-1, insulin-like growth factor-1; CRH, corticotropin-releasing hormone; TRH, thyrotropin releasing hormone; GnRH, gonadotropin releasing hormone; GHRP2 growth hormone releasing peptide 2.